GO
Loading...

Roche's $8.3 billion deal for InterMune

Monday, 25 Aug 2014 | 9:06 AM ET

Drug giant Roche is buying biotech firm InterMune for $8.3 billion. CNBC's Jim Cramer discusses the lifesaving drug behind the wave of M&A deals.